8don MSNOpinion
I was a doctor caring for Alzheimer’s patients. At 57, I became one. Here’s what’s next
Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...
Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...
An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers. NRTIs (nucleoside reverse transcriptase inhibitors) are antivirals that are approved ...
A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...
Repurposing treatments to treat multiple conditions is quicker, safer, and less expensive than developing new ways to manage ...
SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears to slow memory loss, giving patients the gift of more time. UW Medicine's ...
New findings suggest that targeting inflammation in Alzheimer’s may matter as much as targeting protein buildup.
Scientists reverse Alzheimer's memory loss in mice by using NAD+ to restore brain energy, defying decades of research.
Ultrasound therapy is emerging as a potential treatment for Alzheimer’s disease. It uses ultrasound to open the blood-brain barrier, which can help with drug delivery and may also reduce plaques from ...
A new study found that women who test positive for A Parkinson-s related protein accumulated tau at a much faster rate, indicating that it may act as an Alzheimer's disease accelerator.
Morning Overview on MSN
Common gene variant may raise Alzheimer’s risk; researchers eye gene therapy
A genetic variant carried by at least one-fifth of the population may do far more than raise the odds of developing Alzheimer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results